MEDTECH

articles with this tag

One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market

One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market

MagSense is a unique, non-invasive, patent protected technology that fits into myriad addressable cancer diagnostic markets collectively worth $166 billion dollars and growing at 7% annually.

READ ARTICLE

IMU’s Latest Cancer Treatment Acquisition Could Have Big Pharma Knocking

IMU’s Latest Cancer Treatment Acquisition Could Have Big Pharma Knocking

Imugene Limited (ASX:IMU) has negotiated to acquire a worldwide exclusive license to a promising OV developed at LA’s City of Hope Hospital.

READ ARTICLE

Thanks for subscribing!

X